The UK health authorities said on Friday that people under 40 will be offered an alternative to the Oxford/AstraZeneca CCP virus vaccine. According to the UK’s medicines regulator, Medicines and Healthcare products Regulatory Agency (MHRA), 49 people have died after developing blood clots following vaccination with the AstraZeneca shot. As of April 28, there have been 242 cases of post-vaccination blood clotting events, which occurred in 141 women and 100 men aged from 18 to 93 years. Professor Wei Shen Lim, COVID-19 chairman for JCVI, said: “We have continued to assess the benefit/risk balance of COVID-19 vaccines in light of UK infection rates and the latest information from the MHRA on the extremely rare event of blood clots and low platelet counts following vaccination. “As COVID-19 rates continue to come under control, we are advising that adults aged 18 to 39 years with no underlying health conditions are offered an …